Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms

Leah A. Goldberg; James J. Yoon; Hannah Johnston; Marta B. Davidson; Alexa Siddon; Rory M. Shallis; Evan C. Chen; Madelyn Burkart; Timothy S. Oh; Sunil G. Iyer; Ellen Madarang; Chandrasekar Muthiah; Joshua Kassner; Raajit K. Rampal; Guru Subramanian Guru Murthy; Terrence Bradley; Yasmin Abaza; Jacqueline S. Garcia; Vikas Gupta; Kristen M. Pettit; Olatoyosi Odenike; John F. Cursio; Anand A. Patel

Journal ArticleOPEN ACCESS

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms

Blood Neoplasia (2025) 2(2)

DOI: 10.1016/j.bneo.2025.100089

1Citations

1Readers

Cite

CITATION STYLE

APA

Goldberg, L. A., Yoon, J. J., Johnston, H., Davidson, M. B., Siddon, A., Shallis, R. M., … Patel, A. A. (2025). Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms. Blood Neoplasia, 2(2). https://doi.org/10.1016/j.bneo.2025.100089

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms

Cite

Register to see more suggestions